John G. Wise

2.1k total citations
50 papers, 1.8k citations indexed

About

John G. Wise is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, John G. Wise has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in John G. Wise's work include ATP Synthase and ATPases Research (23 papers), Drug Transport and Resistance Mechanisms (15 papers) and Mitochondrial Function and Pathology (14 papers). John G. Wise is often cited by papers focused on ATP Synthase and ATPases Research (23 papers), Drug Transport and Resistance Mechanisms (15 papers) and Mitochondrial Function and Pathology (14 papers). John G. Wise collaborates with scholars based in United States, Germany and Canada. John G. Wise's co-authors include Alan E. Senior, Lisa R. Latchney, Pia D. Vogel, A.E. Senior, Courtney A. Follit, Amila K. Nanayakkara, Kevin G. Chen, Noelle S. Williams, Paul D. Boyer and David S. Perlin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

John G. Wise

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John G. Wise United States	22	1.5k	363	135	111	105	50	1.8k
Marwan K. Al‐Shawi United States	34	2.0k 1.3×	1.3k 3.6×	99 0.7×	94 0.8×	393 3.7×	47	3.0k
Karin Fritz‐Wolf Germany	23	1.3k 0.9×	292 0.8×	252 1.9×	93 0.8×	14 0.1×	38	2.0k
Ganesaratnam K. Balendiran United States	18	991 0.7×	190 0.5×	191 1.4×	10 0.1×	87 0.8×	39	1.9k
Jordan L. Meier United States	33	2.8k 1.9×	287 0.8×	110 0.8×	13 0.1×	19 0.2×	88	3.3k
John M. Whiteley United States	21	961 0.6×	71 0.2×	239 1.8×	17 0.2×	41 0.4×	65	1.4k
Minkui Luo United States	29	2.2k 1.5×	153 0.4×	89 0.7×	15 0.1×	23 0.2×	58	2.5k
Ling Liang China	20	735 0.5×	152 0.4×	204 1.5×	24 0.2×	13 0.1×	63	1.5k
Jeffrey P. Krise United States	24	802 0.5×	248 0.7×	63 0.5×	5 0.0×	70 0.7×	37	1.6k
Jun‐yong Choe United States	25	1.1k 0.7×	119 0.3×	256 1.9×	15 0.1×	16 0.2×	52	1.6k

Countries citing papers authored by John G. Wise

Since Specialization

Citations

This map shows the geographic impact of John G. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Wise more than expected).

Fields of papers citing papers by John G. Wise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Wise. The network helps show where John G. Wise may publish in the future.

Co-authorship network of co-authors of John G. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Wise. A scholar is included among the top collaborators of John G. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Wise. John G. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Follit, Courtney A., et al.. (2025). Computationally accelerated identification of P-glycoprotein inhibitors. PLoS ONE. 20(8). e0325121–e0325121.

Wise, John G., et al.. (2021). Transport Dynamics of MtrD: An RND Multidrug Efflux Pump from Neisseria gonorrhoeae. Biochemistry. 60(41). 3098–3113. 2 indexed citations

Chen, Kevin G., et al.. (2021). Transport of Alzheimer’s associated amyloid-β catalyzed by P-glycoprotein. PLoS ONE. 16(4). e0250371–e0250371. 28 indexed citations

Vogel, Pia D., et al.. (2020). Inhibition of BCRP in Multidrug Resistant Cancer using Novel Inhibitors. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

Nanayakkara, Amila K., Pia D. Vogel, & John G. Wise. (2019). Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells. PLoS ONE. 14(6). e0217940–e0217940. 17 indexed citations

Wise, John G., et al.. (2019). Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches. Journal of Medicinal Chemistry. 62(23). 10645–10663. 20 indexed citations

Nanayakkara, Amila K., Courtney A. Follit, Kevin G. Chen, et al.. (2018). Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Scientific Reports. 8(1). 967–967. 224 indexed citations

Follit, Courtney A., et al.. (2017). Cationic branched polymers for cellular delivery of negatively charged cargo. Journal of Drug Delivery Science and Technology. 39. 324–333. 5 indexed citations

Follit, Courtney A., et al.. (2014). In Silico Screening for Inhibitors of P-Glycoprotein That Target the Nucleotide Binding Domains. Molecular Pharmacology. 86(6). 716–726. 25 indexed citations

10.

Wise, John G.. (2012). Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding Sites. Biochemistry. 51(25). 5125–5141. 75 indexed citations

11.

Wise, John G. & Pia D. Vogel. (2008). Subunit b-Dimer of the Escherichia coli ATP Synthase Can Form Left-Handed Coiled-Coils. Biophysical Journal. 94(12). 5040–5052. 11 indexed citations

12.

Lill, Holger, et al.. (2008). De-novo modeling and ESR validation of a cyanobacterial FoF1–ATP synthase subunit bb′ left-handed coiled coil. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1787(3). 183–190. 3 indexed citations

13.

Hornung, Tassilo, et al.. (2008). Structure of the Cytosolic Part of the Subunit b-Dimer of Escherichia coli F0F1-ATP Synthase. Biophysical Journal. 94(12). 5053–5064. 12 indexed citations

14.

Hornung, Tassilo, et al.. (2008). Conformational changes in the Escherichia coli ATP synthase b-dimer upon binding to F1-ATPase. Journal of Bioenergetics and Biomembranes. 40(6). 551–559. 2 indexed citations

15.

Hornung, Tassilo, et al.. (2004). The Subunit b Dimer of the FoF1-ATP Synthase. Journal of Biological Chemistry. 279(47). 49074–49081. 16 indexed citations

16.

Guo, Chenyun, Zhuoyu Li, Yawei Shi, et al.. (2004). Intein-mediated fusion expression, high efficient refolding, and one-step purification of gelonin toxin. Protein Expression and Purification. 37(2). 361–367. 35 indexed citations

17.

Coan, Carol, et al.. (2002). New aspects on the mechanism of GroEL-assisted protein folding. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1596(2). 326–335. 3 indexed citations

18.

Chelius, Dirk, Sidney Fleischer, J. Oliver McIntyre, et al.. (2000). Phosphatidylcholine Activation of Human Heart (R)-3-Hydroxybutyrate Dehydrogenase Mutants Lacking Active Center Sulfhydryls: Site-Directed Mutagenesis of a New Recombinant Fusion Protein. Biochemistry. 39(32). 9687–9697. 11 indexed citations

19.

Wise, John G.. (1997). Hay fever drug to become prescription only. BMJ. 314(7090). 1297.5–1297.5. 4 indexed citations

20.

Wise, John G., Brian J. Hicke, & Paul D. Boyer. (1987). Catalytic and noncatalytic nucleotide binding sites of the Escherichia coli F₁ ATPase Amino acid sequences of β‐subunit tryptic peptides labeled with 2‐azido‐ATP. FEBS Letters. 223(2). 395–401. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact